CRL

Charles River Laboratories International Stock Analysis

AI Rating

Fair
  • Quality5/10
  • Growth↓ 1/10
  • Value↓ 1/10
Charles River Laboratories International sales and earnings growth
CRL Growth
Low
  • Revenue Y/Y↓ 0.11%
  • EPS Y/Y↓ -516.67%
  • FCF Y/Y↓ -30.53%
Charles River Laboratories International gross and profit margin trends
CRL Profitability
Neutral
  • Gross margin ↑ 32.30%
  • EPS margin↓ -4.60%
  • ROIC 5Y↓ 6.77%
Charles River Laboratories International net debt vs free cash flow
CRL Risk
Good
  • Debt / Equity↓ 1.0
  • Debt / FCF↑ 7.3
  • Interest coverage↓ -0.6

Charles River Laboratories International stock volatility is higher than the overall market. We give it a Good risk rating.

↗ More Diagnostics & Research stocks